VRXA CIK: 2079109

Veraxa Biotech AG - Post de-SPAC

  • Germany
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions CHF
FY23:
11.9
FY24:
5.61
FY25:
2.88
(positive)
Change from FY23 to FY25
millions CHF
FY23:
80.1
FY24:
79.2
FY25:
77.9
Total assets
Change from FY23 to FY25
millions CHF
FY23:
91.9
FY24:
84.8
FY25:
80.8

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions CHF
FY23:
1.61
FY24:
2.55
FY25:
6.61
(negative)
Change from FY23 to FY25
millions CHF
FY23:
35.2
FY24:
51.2
FY25:
90.0
(positive)
Change from FY23 to FY25
millions CHF
FY23:
55.1
FY24:
31.1
FY25:
−15.8
Total liabilities & equity
Change from FY23 to FY25
millions CHF
FY23:
91.9
FY24:
84.8
FY25:
80.8

All amounts in millions CHF Data source:Twelve Data